Video Experimental Relacionado
Updated: Jan 7, 2026

07:42
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
5.6K
La puntuación de aptitud inmune DDR: un biomarcador para guiar la sinergia entre parp y inmunoterapia en el cáncer de
Yinxu Zhang1, Xiaoyang Chen2, Dai Wang2
1Department of Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China.
Frontiers in oncology
|January 5, 2026
Resumen
No abstract available in PubMed .

